Search for: "Warner Chilcott Corporation" Results 1 - 9 of 9
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Aug 2011, 7:56 am by Sonya Hubbard
That is the case for Anthony Bruno, the Executive Vice President, Corporate Development of Warner Chilcott plc (WCRX), a “global specialty pharmaceutical company” headquartered in Dublin, Ireland. [read post]
2 Nov 2015, 2:05 pm by Michael Rosenblat
The company, Warner Chilcott, agreed to pay $102.06 million to resolve a False Claims Act, Whistleblower qui tam lawsuit. [read post]
28 Feb 2022, 10:46 am by Seeger Weiss
With concentration in the areas of health care and tax fraud, Stephen has represented relators in cases against CareCore National, Warner Chilcott and Life Spine, Inc., and led the first settlement ever reached under the 2010 tax whistleblower amendments to New York’s False Claims Act. [read post]
8 Sep 2011, 11:04 am by Tom Lamb
According to the FDA's Announcement for this September 2011 meeting, these two advisory committees will consider the benefits and risks of long-term use of osteoporosis medications in the bisphosphonate class of drugs, which were identified by the FDA as: FOSAMAX (alendronate sodium) tablets and solution and FOSAMAX PLUS D (alendronate sodium/cholecalciferol) tablets, Merck & Co., Inc.; ACTONEL (risedronate sodium) tablets, ATELVIA (risedronate sodium) delayed release tablets, and… [read post]
18 Jan 2023, 1:21 pm by Seeger Weiss
With concentration in the areas of health care and tax fraud, Stephen has represented relators in cases against CareCore National, Warner Chilcott and Life Spine, Inc., and led the first settlement ever reached under the 2010 tax whistleblower amendments to New York’s False Claims Act. [read post]
15 Apr 2010, 4:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: CAFC denies Vanderbilt’s claim to Cialis patent right: Vanderbilt University v ICOS Corporation (Patently-O) (IPBiz) Paris District Court: Basic patent for Losartan covers any product comprising Losartan: Du Pont v Mylan Losartan SPC case (EPLAW)   General WHO documents from counterfeit meeting now online (IP… [read post]
26 Oct 2011, 2:30 am by Marie Louise
GlaxoSmithKline (Holman’s Biotech IP Blog) Femcon Fe (Norethindrone, Ethinyl estradiol) – US: Famy Care and Mylan settle Femcon Fe lawsuit with Warner Chilcott (Patent Circle) Fentanyl – EU: Agreement over pain killer a tender issue in Europe (IP Whiteboard) Quetiapine – Bulgaria: Quetiapine and Bulgaria’s transitional ruling: AstraZeneca v Bulgarian Patent Office (The SPC Blog) Thalomid (Thalidomide, Mephalan, Prednisone) – Australia: APO: No… [read post]